Chen et al. (2017) reported that AIM2 acts as a tumor suppressor by blocking G1-to-S-phase cell cycle transition and suppressing the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway [129]. Here, AIM2 is linked to neoplasm.